More than 700 million adults and children worldwide are obese, according to a 2017 study that called the growing number and weight-related health problems a "rising pandemic."
Dec 17, 2018
1
170
Some vaccinated people infected with COVID-19 in Wisconsin in June and July had just as much virus in their nasal passages as newly infected unvaccinated people, according to a new study published Saturday ahead of peer review ...
Aug 5, 2021
0
14
(Medical Xpress) -- For the first time, scientists at the University of Wisconsin-Madison have made early retina structures containing proliferating neuroretinal progenitor cells using induced pluripotent stem (iPS) cells ...
Mar 14, 2012
0
0
A second line of defense—the immune system's T cells—may offer protection from COVID-19 even when vaccine-induced antibodies no longer can, according to new research out of the University of Wisconsin School of Veterinary ...
May 16, 2022
0
63
(Medical Xpress) -- Researchers at the University of Wisconsin-Madison and collaborators have discovered a powerful new protein in the eye of the fruit fly that may shed light on blinding diseases and other sensory problems ...
Nov 17, 2011
0
0
There's a reason so many children are prescribed methylphenidate, better known by the trade name Ritalin: it helps kids quell attention and hyperactivity problems and sit still enough to focus on a school lesson.
Dec 13, 2018
0
682
For children, stress can go a long way. A little bit provides a platform for learning, adapting and coping. But a lot of it—chronic, toxic stress like poverty, neglect and physical abuse—can have lasting negative impacts.
Jun 27, 2014
0
2
A new study from the University of Wisconsin–Madison suggests that chemotherapy may not be reaching its full potential, in part because researchers and doctors have long misunderstood how some of the most common cancer ...
Oct 27, 2023
0
43
An ongoing lack of sleep during adolescence could lead to more than dragging, foggy teens, a University of Wisconsin-Madison study suggests.
Oct 9, 2011
0
0
The antiviral therapies remdesivir, molnupiravir, and the active ingredient in Pfizer's Paxlovid pill (nirmatrelvir), remain effective in laboratory tests against the BA.2 variant of SARS-CoV-2, the virus that causes COVID-19.
Mar 10, 2022
0
123
